ISSN (Print): 1874-4710 ISSN (Online): 1874-4729 Volume 14, 4 Issues, 2021
Download PDF Flyer
Open Access Funding Promote Your Article
ISSN (Print): 1874-4710 ISSN (Online): 1874-4729
Aims & Scope Abstracted/Indexed in
Emerging Sources Citation Index (ESCI), MEDLINE/PubMed, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, ChemWeb, Google Scholar, Media Finder®-Standard Periodical Directory, Genamics Journal Seek, PubsHub, J-Gate, CNKI Scholar, Suweco CZ, EBSCO, Ulrich's Periodicals Directory, JournalTOCs and Dimensions.
Submit Abstracts / Manuscripts Online Animated Abstract Submission
View Full Editorial Board
Journal Home Editorial Policies Publishing Ethics Self Archiving Policies Reviewer Guidelines Instructions for Authors Free Copies Online Open Access Articles Most Cited Articles Advertise With Us Most Accessed Articles Highlighted Article Trial Requests Library Recommendation Most Popular Articles Thematic Issues Special Issue Submission Subscribe
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.
PET/CT and the Response to Immunotherapy in Lung Cancer open access plus
Volume: 13 Issue: 3 Pp: 177-184 Laura Evangelista*, Matteo Sepulcri and Giulia Pasello DOI: 10.2174/1874471013666191220105449
Toward the Discovery and Development of PSMA Targeted Inhibitors for Nuclear Medicine Applications open access plus
Volume: 13 Issue: 1 Pp: 63-79 Sara Pastorino, Mattia Riondato, Licia Uccelli, Giampiero Giovacchini, Elisabetta Giovannini, Valerio Duce and Andrea Ciarmiello* DOI: 10.2174/1874471012666190729151540
Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions open access plus
Volume: 13 Issue: 3 Pp: 218-227 Cinzia Crivellaro and Luca Guerra* DOI: 10.2174/1874471013666200317144629
18F-FDG PET/CT in Restaging and Evaluation of Response to Therapy in Lung Cancer: State of the Art open access plus
Volume: 13 Issue: 3 Pp: 228-237 Angelo Castello , Sabrina Rossi and Egesta Lopci * DOI: 10.2174/1874471013666191230144821
Alternative and New Radiopharmaceutical Agents for Lung Cancer open access plus
Volume: 13 Issue: 3 Pp: 185-194 Silvi Telo*, Letizia Calderoni, Sara Vichi, Federico Zagni, Paolo Castellucci and Stefano Fanti DOI: 10.2174/1874471013666191223151402
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy open access plus
Volume: 13 Issue: 3 Pp: 243-248 Marco Spadafora*, Laura Evangelista, Salvatore Fiordoro, Francesco Porcaro, Marilena Sicignano and Luigi Mansi DOI: 10.2174/1874471013666200318142210
Lung Cancer and Radiological Imaging open access plus
Volume: 13 Issue: 3 Pp: 238-242 Annalori Panunzio* and Paolo Sartori DOI: 10.2174/1874471013666200523161849
Potential of Radiolabeled PSMA PET/CT or PET/MRI Diagnostic Procedures in Gliomas/Glioblastomas open access plus
Volume: 13 Issue: 2 Pp: 94-98 Francesco Bertagna*, Domenico Albano, Elisabetta Cerudelli, Maria Gazzilli, Raffaele Giubbini and Giorgio Treglia DOI: 10.2174/1874471012666191017093721
99mTc-EDDA/HYNIC-TOC is a New Opportunity in Neuroendocrine Tumors of the Lung (and in other Malignant and Benign Pulmonary Diseases) open access plus
Volume: 13 Issue: 3 Pp: 166-176 Vittorio Briganti, Vincenzo Cuccurullo*, Valentina Berti, Giuseppe D. Di Stasio, Flavia Linguanti, Francesco Mungai and Luigi Mansi DOI: 10.2174/1874471013666191230143610
Radiotherapy Planning and Molecular Imaging in Lung Cancer open access plus
Volume: 13 Issue: 3 Pp: 204-217 Angelina Filice*, Massimiliano Casali, Patrizia Ciammella, Marco Galaverni, Federica Fioroni, Cinzia Iotti and Annibale Versari DOI: 10.2174/1874471013666200318144154
FDG PET/CT in the Staging of Lung Cancer open access plus
Volume: 13 Issue: 3 Pp: 195-203 Mohsen Farsad* DOI: 10.2174/1874471013666191223153755
In situ Generated 212Pb-PSMA Ligand in a 224Ra-Solution for Dual Targeting of Prostate Cancer Sclerotic Stroma and PSMA-positive Cells open access plus
Volume: 13 Issue: 2 Pp: 130-141 Vilde Y. Stenberg, Asta Juzeniene*, Øyvind S. Bruland and Roy H. Larsen DOI: 10.2174/1874471013666200511000532
Analysis of Cell Fraction of 99mTc-HMPAO Radiolabeled Leukocytes open access plus
Volume: 13 Issue: 2 Pp: 142-148 Eun-Mi Kim, Hwan-Jeong Jeong*, Seok-Tae Lim and Myung-Hee Sohn DOI: 10.2174/1874471013666200510015742
Evidence-Based Data About Prevalence and Risk of Malignancy of Thyroid Incidentalomas Detected by Different PET Radiopharmaceuticals
Volume: 13 Issue: 2 Pp: 89-93 Giovanni Signore, Domenico Albano, Luca Giovanella, Francesco Bertagna and Giorgio Treglia* DOI: 10.2174/1874471012666191212115732
Oxidant and Antioxidant Effects of Gentisic Acid in a 177Lu-Labelled Methionine-Containing Minigastrin Analogue open access plus
Volume: 13 Issue: 2 Pp: 107-119 Victoria Trindade* and Henia Balter DOI: 10.2174/1874471012666190916112904
Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration open access plus
Volume: 13 Issue: 2 Pp: 159-163 Viviana Frantellizzi*, Mariano Pontico, Arianna Pani, Roberto Pani and Giuseppe De Vincentis DOI: 10.2174/1874471012666190927115331
Radioiodination of Pimonidazole as a Novel Theranostic Hypoxia Probe
Volume: 14 Issue: 1 Pp: 46-50 Ilknur Demir Inci, Volkan Tekin, Ayfer Yurt Kilcar, Ozge Kozgus Guldu, Emin Ilker Medine, Kadriye Busra Karatay, Emine Dervis and Fazilet Zumrut Biber Muftuler* DOI: 10.2174/1874471013666200331114908
view more
